Delay Between Shaking and Actuation of a Hydrofluoroalkane Fluticasone Pressurized Metered-Dose Inhaler

References

1. 1.↵
   Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA) 2015. http://ginasthma.org/wp-content/uploads/2016/01/GINA_Report_2015_Aug11-1.pdf. Accessed October 17, 2017.
2. 2.↵
   1. Laube BL,
   2. Janssens HM,
   3. de Jongh FH,
   4. Devadason SG,
   5. Dhand R,
   6. Diot P,
   7. et al

   . What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J 2011;37(6):1308–1331.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Devadason SG,
   2. Le Souef PN

   . Age-associated factors influencing the efficacy of various forms of aerosol therapy. J Aerosol Med 2002;15(3):343–345.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Newman SP

   . Principles of metered-dose inhaler design. Respir Care 2005;50(9):1177–1190.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Hatley RH,
   2. Parker J,
   3. Pritchard JN,
   4. von Hollen D

   . Variability in delivered dose from pressurized metered-dose inhaler formulations due to a delay between shake and fire. J Aerosol Med Pulm Drug Deliv 2017;30(1):71–79.

   OpenUrl
6. 6.↵
   1. Berlinski A,
   2. von Hollen D,
   3. Hatley RHM,
   4. Hardaker LEA,
   5. Nikander K

   . Drug delivery in asthmatic children following coordinated and uncoordinated inhalation maneuvers: a randomized crossover trial. J Aerosol Med Pulm Drug Deliv 2017;30(3):182–189.

   OpenUrl
7. 7.↵
   1. Berg E

   . In vitro properties of pressurized metered dose inhalers with and without spacer devices. J Aerosol Med 1995;8 (Suppl 3):S3–S10; discussion S11.

   OpenUrl